Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


Articles published in Semin Nephrol

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    July 2018
  1. GEDNEY N, Kalantar-Zadeh K
    Dialysis Patient-Centeredness and Precision Medicine: Focus on Incremental Home Hemodialysis and Preserving Residual Kidney Function.
    Semin Nephrol. 2018;38:426-432.
    PubMed     Text format     Abstract available


  2. WANG AY, Kalantar-Zadeh K, Fouque D, Wee PT, et al
    Precision Medicine for Nutritional Management in End-Stage Kidney Disease and Transition to Dialysis.
    Semin Nephrol. 2018;38:383-396.
    PubMed     Text format     Abstract available


  3. RHEE CM, Obi Y, Mathew AT, Kalantar-Zadeh K, et al
    Precision Medicine in the Transition to Dialysis and Personalized Renal Replacement Therapy.
    Semin Nephrol. 2018;38:325-335.
    PubMed     Text format     Abstract available


  4. USVYAT L, Dalrymple LS, Maddux FW
    Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:418-425.
    PubMed     Text format     Abstract available


  5. BRIER ME, Gaweda AE, Aronoff GR
    Personalized Anemia Management and Precision Medicine in ESA and Iron Pharmacology in End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:410-417.
    PubMed     Text format     Abstract available


  6. JOVANOVICH A, Kendrick J
    Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:397-409.
    PubMed     Text format     Abstract available


  7. STREJA E, Streja DA, Soohoo M, Kleine CE, et al
    Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:369-382.
    PubMed     Text format     Abstract available


  8. GOSMANOVA EO, Kovesdy CP
    Patient-Centered Approach for Hypertension Management in End-Stage Kidney Disease: Art or Science?
    Semin Nephrol. 2018;38:355-368.
    PubMed     Text format     Abstract available


  9. DAFOE DC, Tantisattamo E, Reddy U
    Precision Medicine and Personalized Approach to Renal Transplantation.
    Semin Nephrol. 2018;38:346-354.
    PubMed     Text format     Abstract available


  10. DAVISON SN
    Personalized Approach and Precision Medicine in Supportive and End-of-Life Care for Patients With Advanced and End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:336-345.
    PubMed     Text format     Abstract available


  11. KOPP JB, Winkler CA
    Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease.
    Semin Nephrol. 2018;38:317-324.
    PubMed     Text format     Abstract available


  12. MORADI H, Kalantar-Zadeh K
    Introduction: Precision Medicine in End-Stage Kidney Disease and Personalized Renal Replacement Therapy: Challenges and Unmet Need.
    Semin Nephrol. 2018;38:315-316.
    PubMed     Text format    


    May 2018
  13. JEGATHEESAN D, Cho Y, Johnson DW
    Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients.
    Semin Nephrol. 2018;38:277-290.
    PubMed     Text format     Abstract available


  14. HENAUT L, Chillon JM, Kamel S, Massy ZA, et al
    Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease.
    Semin Nephrol. 2018;38:233-250.
    PubMed     Text format     Abstract available


    March 2018
  15. LI DY, Tang WHW
    Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Semin Nephrol. 2018;38:193-205.
    PubMed     Text format     Abstract available


    November 2017
  16. ESTRELLA MM, Parekh RS
    The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease.
    Semin Nephrol. 2017;37:520-529.
    PubMed     Text format     Abstract available


    July 2017
  17. AHMED SB
    Menopause and Chronic Kidney Disease.
    Semin Nephrol. 2017;37:404-411.
    PubMed     Text format     Abstract available


  18. BRAMHAM K
    Pregnancy in Renal Transplant Recipients and Donors.
    Semin Nephrol. 2017;37:370-377.
    PubMed     Text format     Abstract available


  19. HLADUNEWICH MA
    Chronic Kidney Disease and Pregnancy.
    Semin Nephrol. 2017;37:337-346.
    PubMed     Text format     Abstract available


  20. AHMED SB, Vitek WS, Holley JL
    Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease.
    Semin Nephrol. 2017;37:327-336.
    PubMed     Text format     Abstract available


  21. DIAZ-GONZALEZ DE FERRIS ME, Alvarez-Elias AC, Ferris MT, Medeiros M, et al
    Female Adolescents with Chronic or End-Stage Kidney Disease and Strategies for their Care.
    Semin Nephrol. 2017;37:320-326.
    PubMed     Text format     Abstract available


    May 2017
  22. CHUENGSAMAN P, Kasemsup V
    PD First Policy: Thailand's Response to the Challenge of Meeting the Needs of Patients With End-Stage Renal Disease.
    Semin Nephrol. 2017;37:287-295.
    PubMed     Text format     Abstract available


  23. LUYCKX VA, Miljeteig I, Ejigu AM, Moosa MR, et al
    Ethical Challenges in the Provision of Dialysis in Resource-Constrained Environments.
    Semin Nephrol. 2017;37:273-286.
    PubMed     Text format     Abstract available


  24. CARRERO JJ, Hecking M, Ulasi I, Sola L, et al
    Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective.
    Semin Nephrol. 2017;37:296-308.
    PubMed     Text format     Abstract available


  25. DAVIDS MR, Caskey FJ, Young T, Balbir Singh GK, et al
    Strengthening Renal Registries and ESRD Research in Africa.
    Semin Nephrol. 2017;37:211-223.
    PubMed     Text format     Abstract available


    March 2017
  26. RIVARA MB, Mehrotra R
    Timing of Dialysis Initiation: What Has Changed Since IDEAL?
    Semin Nephrol. 2017;37:181-193.
    PubMed     Text format     Abstract available


  27. MOIST LM, Lok CE
    Incident Dialysis Access in Patients With End-Stage Kidney Disease: What Needs to Be Improved.
    Semin Nephrol. 2017;37:151-158.
    PubMed     Text format     Abstract available


  28. BANSAL N
    Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
    Semin Nephrol. 2017;37:120-131.
    PubMed     Text format     Abstract available


  29. FOLEY RN
    Epidemiology and Risk Factors for Early Mortality After Dialysis Initiation.
    Semin Nephrol. 2017;37:114-119.
    PubMed     Text format     Abstract available


  30. KURELLA TAMURA M
    Optimizing the Transition to End-Stage Renal Disease.
    Semin Nephrol. 2017;37:113.
    PubMed     Text format    


  31. WAGNER LA, Fink JC
    Ensuring Patient Safety During the Transition to ESRD.
    Semin Nephrol. 2017;37:194-208.
    PubMed     Text format     Abstract available


  32. SCHMIDT RJ
    Advance Care Planning for Patients Approaching End-Stage Kidney Disease.
    Semin Nephrol. 2017;37:173-180.
    PubMed     Text format     Abstract available


  33. SHESHADRI A, Johansen KL
    Prehabilitation for the Frail Patient Approaching ESRD.
    Semin Nephrol. 2017;37:159-172.
    PubMed     Text format     Abstract available


  34. SUMIDA K, Kovesdy CP
    Disease Trajectories Before ESRD: Implications for Clinical Management.
    Semin Nephrol. 2017;37:132-143.
    PubMed     Text format     Abstract available


    January 2017
  35. CHO Y, Struijk DG
    Peritoneal Dialysis-Related Peritonitis: Atypical and Resistant Organisms.
    Semin Nephrol. 2017;37:66-76.
    PubMed     Text format     Abstract available


  36. LI PK, Ng JK, Mcintyre CW
    Inflammation and Peritoneal Dialysis.
    Semin Nephrol. 2017;37:54-65.
    PubMed     Text format     Abstract available


  37. KIM YL, Biesen WV
    Fluid Overload in Peritoneal Dialysis Patients.
    Semin Nephrol. 2017;37:43-53.
    PubMed     Text format     Abstract available


  38. SZETO CC, Johnson DW
    Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.
    Semin Nephrol. 2017;37:30-42.
    PubMed     Text format     Abstract available


  39. CRABTREE JH, Chow KM
    Peritoneal Dialysis Catheter Insertion.
    Semin Nephrol. 2017;37:17-29.
    PubMed     Text format     Abstract available


  40. YU X, Mehrotra R, Yang X
    Components of A Successful Peritoneal Dialysis Program.
    Semin Nephrol. 2017;37:10-16.
    PubMed     Text format     Abstract available


  41. ALSTON H, Fan S, Nakayama M
    Encapsulating Peritoneal Sclerosis.
    Semin Nephrol. 2017;37:93-102.
    PubMed     Text format     Abstract available


  42. BAJO MA, Del Peso G, Teitelbaum I
    Peritoneal Membrane Preservation.
    Semin Nephrol. 2017;37:77-92.
    PubMed     Text format     Abstract available


  43. LI PK, Kwong VW
    Current Challenges and Opportunities in PD.
    Semin Nephrol. 2017;37:2-9.
    PubMed     Text format     Abstract available


    November 2016
  44. BREYER MD, Susztak K
    Developing Treatments for Chronic Kidney Disease in the 21st Century.
    Semin Nephrol. 2016;36:436-447.
    PubMed     Text format     Abstract available


    September 2016
  45. ABAD CL, Razonable RR
    alpha Herpes Virus Infections Among Renal Transplant Recipients.
    Semin Nephrol. 2016;36:344-350.
    PubMed     Text format     Abstract available


    July 2016
  46. WANG V, Vilme H, Maciejewski ML, Boulware LE, et al
    The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
    Semin Nephrol. 2016;36:319-30.
    PubMed     Text format     Abstract available


  47. PENA-POLANCO JE, Fried LF
    Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
    Semin Nephrol. 2016;36:331-42.
    PubMed     Text format     Abstract available


  48. HSU RK, Hsu CY
    The Role of Acute Kidney Injury in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:283-92.
    PubMed     Text format     Abstract available


  49. COLLISTER D, Ferguson T, Komenda P, Tangri N, et al
    The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review.
    Semin Nephrol. 2016;36:273-82.
    PubMed     Text format     Abstract available


  50. PANWAR B, Gutierrez OM
    Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:252-61.
    PubMed     Text format     Abstract available


    March 2016
  51. SHAH HH, Hazzan AD, Fishbane S
    Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
    Semin Nephrol. 2016;36:124-9.
    PubMed     Text format     Abstract available


  52. PANDEY R, Daloul R, Coyne DW
    Iron Treatment Strategies in Dialysis-Dependent CKD.
    Semin Nephrol. 2016;36:105-11.
    PubMed     Text format     Abstract available


  53. BLOCK GA
    Ferric Citrate in Patients With Chronic Kidney Disease.
    Semin Nephrol. 2016;36:130-5.
    PubMed     Text format     Abstract available


  54. FISHBANE S
    Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:119-23.
    PubMed     Text format     Abstract available


  55. BAHRAINWALA J, Berns JS
    Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:94-8.
    PubMed     Text format     Abstract available


  56. GANZ T, Nemeth E
    Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:87-93.
    PubMed     Text format     Abstract available


  57. FISHBANE S
    Introduction: Iron Management in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:85-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: